Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (301-310 of 324) with videos related to

Pageof 33
Sort By:
Hepatology (Baltimore, Md.)|December 24, 1998
Impact of hepatitis B and C virus on kidney transplantation outcomeP Mathurin, C Mouquet, T Poynard, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activityP Mathurin, J Moussalli, J F Cadranel, et al.
American Journal of Obstetrics and Gynecology|December 1, 1980
Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction: Chlamydia trachomatis and Ureaplasma urealyticumJ Henry-Suchet, F Catalan, V Loffredo, et al.
Journal of Viral Hepatitis|March 16, 2000
Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infectionsP Mathurin, V Thibault, K Kadidja, et al.
Gut|June 16, 1999
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusP Cresta, L Musset, P Cacoub, et al.
Gastroenterologie Clinique Et Biologique|June 29, 1999
[Treatment of portal hypertension]P Calès, D Castaing, J D Grangé, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2014
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemiaH Perazzo, M Munteanu, Y Ngo, et al.
Pageof 33

Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
Hepatology (Baltimore, Md.)|December 24, 1998
Impact of hepatitis B and C virus on kidney transplantation outcomeP Mathurin, C Mouquet, T Poynard, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Hepatology (Baltimore, Md.)|March 21, 1998
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activityP Mathurin, J Moussalli, J F Cadranel, et al.
American Journal of Obstetrics and Gynecology|December 1, 1980
Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction: Chlamydia trachomatis and Ureaplasma urealyticumJ Henry-Suchet, F Catalan, V Loffredo, et al.
Journal of Viral Hepatitis|March 16, 2000
Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infectionsP Mathurin, V Thibault, K Kadidja, et al.
Gut|June 16, 1999
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusP Cresta, L Musset, P Cacoub, et al.
Gastroenterologie Clinique Et Biologique|June 29, 1999
[Treatment of portal hypertension]P Calès, D Castaing, J D Grangé, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2014
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemiaH Perazzo, M Munteanu, Y Ngo, et al.
Pageof 33